Skip to main content
SpringerLink
Log in

Analogs of thyrotropin-releasing hormone (TRH): Receptor affinities in brains, spinal cords, and pituitaries of different species

  • Original Articles
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

[3H](3-Me-His2) thyrotropin-releasing hormone ([3H]MeTRH) bound to TRH receptors in rodent, rabbit and dog brain and spinal cord (SC), and in rat, sheep, bovine and dog anterior pituitary (PIT) glands, with high affinity (dissociation constants, Kds=5–9 nM; n=3–4) but to different densities of these sites (B max range 6–145 fmol/mg protein) (rabbit SC>sheep PIT≫G.pig brain>dog brain>rat brain>bovine and dog PIT). Various TRH analogs competitively inhibited [3H]MeTRH binding in these tissues with a similar rank order of potency: MeTRH>TRH> CG3703≥RX77368≥MK-771>TRH Glycinamide>Glu1-TRH≫CG3509≥NVal2-TRH>>>TRH free acid>>>and cyclo-His-Pro, indicating a pharmacological similarity of CNS and pituitary TRH receptors. While most TRH analogs displaced [3H]MeTRH binding with a similar potency in the different species, TRH exhibited a 2-fold lower affinity in the rat and G.pig brain than in other tissues of other species. Similarly, CG3703 was 2.4–4.5 times more active in the rabbit brain than in the rodent and dog brain, and also more potent in the rabbit brain as compared to the sheep PIT. However, MK-771 and RX77368 had a similar affinity for the brain TRH receptors in the different species but RX77368 was 2-fold more active in the SC preparations and ≈3–4-fold less active in the sheep PIT when compared to the brain homogenates. RX 77368 exhibited the highest affinity for the dog PIT TRH receptor. In contrast, MK-771 showed a similar affinity for the brain, SC and PIT TRH receptor apart from in the rat PIT where it had the highest affinity. Similarly, TRH glycinamide was more active in the dog brain than rodent and rabbit brain. These data suggest that while the rank order of potency of TRH analogs is similar in the species examined, certain analogs appear to be more potent in certain tissues of some species than in others. In addition, the current results have shown that CG3703 is almost equipotent with RX77368 and MK-771 in most species but is substantially more active than its related analog, CG3509 in the brain, SC and PIT. Taken together, these observations may have some relevance to the future clinical applications of these metabolically stabilized TRH analogs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Blackwell, R.K., and Guillman, R. 1973. Hypothalamic control of adenohypophyseal secretions. Ann. Rev. Physiol. 35:357–390.

    Google Scholar 

  2. Burt, D.R., and Sharif, N.A. 1990. TRH Receptors, Pages 477–503,in Bjorklund, A., Hökfelt T., and M.J. Kuhar, (eds.), Handbook of Chemical Neuroanatomy, Chapter 9, Vol. 9, Academic Press, New York.

    Google Scholar 

  3. Griffiths, E.C. 1987. Clinical applications of thyrotropin-releasing hormone. Clin. Sci. 73:449–457.

    Google Scholar 

  4. Jackson, I.M.D. 1982. Thyrotropin-releasing hormone. N. Engl. J. Med., 306:145–155.

    Google Scholar 

  5. Metcalf, G. 1982. Regulatory peptides as a source of new drugs: the clinical prospects for analogs of TRH which are resistant to metabolic degradation. Brain Res. Rev. 4:389–408.

    Google Scholar 

  6. Sharif, N.A. 1987. Adaptive changes in TRH receptors: effects of lesions, kindling, hormones, drugs and other factors. Med. Sci. Res. 115:223–227.

    Google Scholar 

  7. Gershengorn, M.C. 1986. Thyrotropin-releasing hormone-mechanism of calcium-mediated stimulation of prolactin secretion. Recent Prog. Horm. Res. 41:607–646.

    Google Scholar 

  8. Faden, A.I., Sacksen, I., and Noble, L.J. 1988. Structure activity relationships of TRH analogs in rat spinal cord injury. Brain Res 448:287–293.

    Google Scholar 

  9. McIntosch, T.K., Vink, R., and Faden, A.I. 1988. Analogue of thyrotropin-releasing hormone improves outcome after brain injury:31P-NMR studies. Am. J. Physiol. 254:R785-R792.

    Google Scholar 

  10. Sobue, I., Yamamoto, H., Konagya, M., Lida, M., and Takayangi, T. 1980. Controlled trial of thyrotropin-releasing hormone in ataxia of spinocerebellar degeneration. Lancet 1:418–419.

    Google Scholar 

  11. Engel, W.K., Siddique, T., and Nicoloff, J.T. 1973. Effects of weakness and spasticity in amyotropic lateral sclerosis of thyrotropin-releasing hormone. Lancet. 1:73–75.

    Google Scholar 

  12. Matsuishi, T., Yano, E., Inanaga, K., Terasawa, K., Ishihara, O., Shiotsuki, Y., Katafuchi, Y., Aoki, N., and Yamashita, F. 1983. A pilot study on the anticonvulsive effects of a thyrotropin-releasing hormone analog in intractable epilepsy. Brain Dev. 5:421–428.

    Google Scholar 

  13. Holaday, J.W., D'Amato, R.J., and Faden, A.I. 1981. Thyrotropin-releasing hormone improves cardiovascular function in experimental endotoxic and haemorrhagic shock. Science. 213:216–218.

    Google Scholar 

  14. Sunderland, T., Mellow, A.M., Gross, M., Cohen, R.M., Tariot, P.N., Newhouse, P.A., and Murphy, D.L. 1986. Thyrotropin-releasing hormone and dementia. Am. J. Psych. 143:1318.

    Google Scholar 

  15. Wilk, S. 1989. Inhibitors of TRH-degrading enzymes, Pages 252–264,in Metcalf G. and Jackson I.M.D., (eds), Recent Advances in the Biomedical Significance of Thyrotropin-Releasing Hormone Vol 553; N. Y. Acad. Sci. New York.

    Google Scholar 

  16. Friderichs, E., Schwetner, E., Herring, S., Gunzler, W.A., Otting, F. and Flohé, L. 1981. Activity of thyroliberin analogs with a modified pyroglutamyl residue on the central nervous system. Pages 461–481,In W. Voelter and G. Weitzel (eds.), Structure activity of natural peptides, de Gruyter, Berhim.

    Google Scholar 

  17. Hennies, H.H., and Flohé, L. 1982. Effects of the thyroliberin analogue CG 3703 on noradrenergic and serotonergic transmission in rodents. Biochem. Pharmacol. 31:2430–3432.

    Google Scholar 

  18. Nicoll, R.A. 1977. Excitatory actions of TRH on spinal motoneurons. Nature, 265:242–243.

    Google Scholar 

  19. Hawkins, E.F., Beydoun, S.R., Haun, C.K., and Engel, W.K. 1986. Analogs of thyrotropin-releasing hormone: hypotheses relating to receptor binding to net excitation of spinal lower motor neurons. Biochem. Biophys. Res. Comm. 138:1184–1190.

    Google Scholar 

  20. Rinehart, R.K., Barbaraz, B., Iyengar, F., Ambrose, F., Steel, D.J., Neale, R.F., Petrack, B., Bittiger, H., Wood, P.L., and Williams, M. 1986. Benzodiazepine interactions with central thyrotropin-releasing hormone (TRH) binding sites: characterization and physiological significance. J. Pharmacol. Exp. Ther. 238:178–185.

    Google Scholar 

  21. Sharif, N.A., To, Z, Michel, A.D., and Whiting, R.L. 1989. Differential affinities of TRH analogs at the mammalian spinal cord TRH receptor: implications for therapy in spinal injuries. Neurosci. Lett. 104:183–188.

    Google Scholar 

  22. Sharif, N.A., and Burt, D.R. 1983. Rat brain TRH receptors: kinetics, pharmacology, distribution and ionic effects. Regul. Peptides. 7:399–411.

    Google Scholar 

  23. Sharif, N.A., Towle, A.C., Burt, D.R., Mueller, R.A., and Breese, G.R. 1989. Cotransmitters: differential effects of serotonin (5-HT)-depleting drugs on levels of 5-HT and TRH and their receptors in rat brain and spinal cord. Brain Res., 480:365–371.

    Google Scholar 

  24. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. 1951. Protein measurement with the Folin reagent. J. Biol. Chem. 193:265–275.

    Google Scholar 

  25. Munson, P.J. and Rodbard, D. LIGAND: 1980. A versatile computerized approach for the characterization of ligand binding systems. Anal. Biochem. 107:220–239.

    Google Scholar 

  26. Michel, A.D., and Whiting, R.L. 1984. Analysis of ligand binding data using a microcomputer. Brit. J. Pharmacol. 83:460.

    Google Scholar 

  27. Cheng, Y.C., and Prusoff, W.H. 1973. Relationship between inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzymatic reaction. Biochem. Pharmacol. 22:3099–3108.

    Google Scholar 

  28. Wei, E., Loh, H., and Way, E.L. 1976. Potency of the N3im- methyl analog of TRH in the induction of shaking movements in the rat. Eur. J. Pharmacol. 36:227–229.

    Google Scholar 

  29. Grant, G., Vale, W., and Guillemin, R. 1973. Characteristics of the pituitary binding sites for thyrotropin releasing factors. Endocrinol. 92:1629–1632.

    Google Scholar 

  30. Hinkle, P.M., Woroch, E.L., and Tashjian, A.H. Jr. 1974. Receptor-binding affinities and biological activities of analogs of thyrotropin-releasing hormone in prolactin-producing pituitary cells in culture. J. Biol. Chem. 249:3085–3090.

    Google Scholar 

  31. Sharif, N.A., To, Z., and Whiting, R.L. 1989. First pharmacological characterization of TRH receptors linked to phosphoinositide hydrolysis in GH3 cells using analog specificity of eight TRH analogs. Biochem. Biophys. Res. Comm. 16:1306–1311.

    Google Scholar 

  32. Latham, A., Lye, R.H., Shrewsbury-Gee, J., and Slater, P. 1985. Evaluation of the effects of two TRH analogues on cerebral ischaemia. Reg. Peptides. 13:80.

    Google Scholar 

  33. Horita, A., Carino, M.A., Zabawska, J., and Lai, H. 1989. TRH analog MK-771 reverses neurochemical and learning deficits in medial septal-lesioned rats. Peptides. 10:121–124.

    Google Scholar 

  34. Sharp, T., Tulloch, I.F., Bennett, G.W., Marsden, C.A., Metcalf, G., and Dettmar, P.W. 1984. Analeptic effects of centrally injected TRH and analogues of TRH in the pentobarbitone-anaesthetized rat. Neuropharmacology 23:339–348.

    Google Scholar 

  35. Szirtes, T., Kisfaludy, L., Palosi, E., and Szporny, L. 1984. Synthesis of thyrotropin-releasing hormone analogues. 1. Complete dissociation of central nervous system effects from thyrotropin-releasing activity. J. Med. Chem. 27:741–748.

    Google Scholar 

  36. Maeda-Hagiwara, M., and Taché, Y. 1987. Central nervous system action of TRH to stimulate gastric emptying in rats. Reg. Peptides. 17:199–207.

    Google Scholar 

  37. Munsat, J.L., Mora, J.S., Robinson, J.E., Jackson, I.M.D., Lechan, R., Hedlund, W., Taft, J., Reichlin, S., and Scheife, R. 1984. Intrathecal TRH in amyotropic lateral sclerosis: preliminary observations. Neurol. Suppl. 34:239.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neuroscience, Institute of Pharmacology (R7-101), Syntex Research, 3401 Hillview Ave, 94303, Palo Alto, CA

    N. A. Sharif, Z. P. To & R. L. Whiting

Authors
  1. N. A. Sharif
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Z. P. To
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. L. Whiting
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sharif, N.A., To, Z.P. & Whiting, R.L. Analogs of thyrotropin-releasing hormone (TRH): Receptor affinities in brains, spinal cords, and pituitaries of different species. Neurochem Res 16, 95–103 (1991). https://doi.org/10.1007/BF00965695

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00965695

Key Words

Search

Navigation